J L Calleja Selected Research

J L Calleja Research Topics

5	Fibrosis (Cirrhosis) 10/2017 - 10/2001
5	Chronic Hepatitis C 01/2017 - 02/2001
4	Infections 02/2019 - 07/2015
3	Hepatitis C 10/2017 - 02/2001
3	Liver Diseases (Liver Disease) 05/2015 - 09/2010
3	Chronic Hepatitis B 11/2009 - 02/2006
1	Diabetes Mellitus 02/2019
1	Heart Failure 02/2019
1	Endocarditis 02/2019
1	Portal Hypertension 10/2017
1	Virus Diseases (Viral Diseases) 01/2017
1	Disease Progression 07/2015
1	Persistent Infection 05/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2010
1	Hepatitis 02/2006
1	Esophageal and Gastric Varices (Esophageal Varices) 10/2001
1	Hemorrhage 10/2001

7	Ribavirin (Virazole)FDA LinkGeneric 10/2017 - 02/2001
5	InterferonsIBA 10/2017 - 02/2001
3	Antiviral Agents (Antivirals)IBA 01/2017 - 10/2009
2	SofosbuvirIBA 10/2017 - 01/2017
2	RNA (Ribonucleic Acid)IBA 05/2015 - 02/2001
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 05/2015 - 11/2014
2	Alanine Transaminase (SGPT)IBA 09/2010 - 02/2001
2	Hepatitis B e AntigensIBA 09/2010 - 02/2006
2	Lamivudine (Epivir)FDA Link 11/2009 - 02/2006
1	Daptomycin FDA Link 02/2019
1	CreatinineIBA 02/2019
1	Vancomycin FDA LinkGeneric 02/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2017
1	paritaprevirIBA 01/2017
1	ombitasvirIBA 01/2017
1	dasabuvirIBA 01/2017
1	SimeprevirIBA 01/2017
1	NucleotidesIBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017
1	Ritonavir (Norvir)FDA Link 01/2017
1	ButyrophilinsIBA 07/2015
1	Indicators and Reagents (Reagents)IBA 05/2014
1	DNA (Deoxyribonucleic Acid)IBA 09/2010
1	Viral DNAIBA 11/2009
1	lipoarabinomannan (LAM)IBA 11/2009
1	adefovirIBA 11/2009
1	adefovir dipivoxil (Hepsera)FDA Link 02/2006
1	Amantadine (Aman)FDA LinkGeneric 10/2003
1	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 10/2001